New Immunotherapy for Stem Cell Transplant to be Introduced at Biotechnology Convention
News
Xenikos B.V. will discuss its lead product candidate T-Guard, designed for acute graft versus host disease (GVHD), at the BIO International Convention 2016, June 6-9, in San Francisco, Calif. Transplantation of allogenic (donor-derived) ... Read more